169 related articles for article (PubMed ID: 36092868)
1. Identification of a chromatin regulator signature and potential prognostic ability for adrenocortical carcinoma.
Li J; Jia Y; Tang L; Zhang R; Zhang Y
Front Genet; 2022; 13():948353. PubMed ID: 36092868
[No Abstract] [Full Text] [Related]
2. Identification of the ferroptosis regulator HELLS with prognostic value for adrenocortical carcinoma based on integrated analysis and experimental validation.
Liu Z; Xie Y; Liu S; Shen S; Zhu Y; Gou Q
Gland Surg; 2023 Sep; 12(9):1251-1270. PubMed ID: 37842529
[TBL] [Abstract][Full Text] [Related]
3. Identification of a Ferroptosis-Related Signature Associated with Prognosis and Immune Infiltration in Adrenocortical Carcinoma.
Chen X; Yan L; Jiang F; Lu Y; Zeng N; Yang S; Ma X
Int J Endocrinol; 2021; 2021():4654302. PubMed ID: 34335745
[TBL] [Abstract][Full Text] [Related]
4. Identification and Verification of Immune-Related Genes Prognostic Signature Based on ssGSEA for Adrenocortical Carcinoma (ACC).
Yuan K; Zeng R; Deng P; Zhang A; Liu H; Wang N; Tang Y; Yin Z; Liu H
Int J Gen Med; 2022; 15():1471-1483. PubMed ID: 35210821
[TBL] [Abstract][Full Text] [Related]
5. Development and Validation of an m6A RNA Methylation Regulators-Based Signature for Predicting the Prognosis of Adrenocortical Carcinoma.
Shen C; Liu J; Yang X; Jiao W; Wang Y
Front Endocrinol (Lausanne); 2021; 12():568397. PubMed ID: 33692753
[TBL] [Abstract][Full Text] [Related]
6. The prognostic value and immunological role of SULF2 in adrenocortical carcinoma.
Yan J; Xie X; Li Q; Liang P; Zhang J; Xu G
Heliyon; 2023 Feb; 9(2):e13613. PubMed ID: 36852051
[TBL] [Abstract][Full Text] [Related]
7. Prognosis and Therapeutic Efficacy Prediction of Adrenocortical Carcinoma Based on a Necroptosis-Associated Gene Signature.
Ji D; Zhong R; Fan S
Biomed Res Int; 2022; 2022():8740408. PubMed ID: 35647181
[TBL] [Abstract][Full Text] [Related]
8. Identification and validation of chromatin regulator-related signatures as a novel prognostic model for low-grade gliomas using translational bioinformatics.
Wang B; Feng Y; Li Z; Zhou F; Luo J; Yang B; Long S; Li X; Liu Z; Li X; Chen J; Wang L; Wei W
Life Sci; 2024 Jan; 336():122312. PubMed ID: 38042284
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive
Xu T; Xu W; Zheng Y; Li X; Cai H; Xu Z; Zou Q; Yu B
Front Immunol; 2022; 13():931906. PubMed ID: 35958598
[TBL] [Abstract][Full Text] [Related]
10. A Novel Pyroptosis-Related Gene Signature for Predicting the Prognosis and the Associated Immune Infiltration in Colon Adenocarcinoma.
Chen Z; Han Z; Nan H; Fan J; Zhan J; Zhang Y; Zhu H; Cao Y; Shen X; Xue X; Lin K
Front Oncol; 2022; 12():904464. PubMed ID: 35912258
[TBL] [Abstract][Full Text] [Related]
11. Bioinformatic analyses and experimental validation of the role of m6A RNA methylation regulators in progression and prognosis of adrenocortical carcinoma.
Xu F; Guan Y; Ma Y; Xue L; Zhang P; Yang X; Chong T
Aging (Albany NY); 2021 Apr; 13(8):11919-11941. PubMed ID: 33952721
[TBL] [Abstract][Full Text] [Related]
12. Identification and validation of differentially expressed chromatin regulators for diagnosis of aortic dissection using integrated bioinformatics analysis and machine-learning algorithms.
Liu C; Zhou Y; Zhao D; Yu L; Zhou Y; Xu M; Tang L
Front Genet; 2022; 13():950613. PubMed ID: 36035141
[No Abstract] [Full Text] [Related]
13. High expression of GMNN predicts malignant progression and poor prognosis in ACC.
Zhao X; Zhang X; Shao S; Yang Q; Shen C; Yang X; Jiao W; Liu J; Wang Y
Eur J Med Res; 2022 Dec; 27(1):301. PubMed ID: 36539849
[TBL] [Abstract][Full Text] [Related]
14. Establishing a prognostic model of chromatin modulators and identifying potential drug candidates in renal clear cell patients.
Liu P; Luo J; Tan N; Li C; Xu J; Yang X
BMC Bioinformatics; 2023 Mar; 24(1):104. PubMed ID: 36941564
[TBL] [Abstract][Full Text] [Related]
15. A transcription factor signature predicts the survival of patients with adrenocortical carcinoma.
Zhao J; Liu B; Li X
PeerJ; 2021; 9():e12433. PubMed ID: 34966575
[TBL] [Abstract][Full Text] [Related]
16. Identification of prognostic metabolic genes in adrenocortical carcinoma and establishment of a prognostic nomogram: A bioinformatic study.
Chen Q; Ren Z; Liu D; Jin Z; Wang X; Zhang R; Liu Q; Cheng W
Medicine (Baltimore); 2021 Dec; 100(50):e27864. PubMed ID: 34918636
[TBL] [Abstract][Full Text] [Related]
17. Identification of a chromatin regulator signature and potential candidate drugs for bladder cancer.
Zhu K; Liu X; Deng W; Wang G; Fu B
Hereditas; 2022 Feb; 159(1):13. PubMed ID: 35125116
[TBL] [Abstract][Full Text] [Related]
18. Exploration of the immune-related signature and immune infiltration analysis for breast ductal and lobular carcinoma.
Zhang B; Wang Q; Fu C; Jiang C; Ma S
Ann Transl Med; 2019 Dec; 7(23):730. PubMed ID: 32042746
[TBL] [Abstract][Full Text] [Related]
19. Integrative transcriptional characterization of cell cycle checkpoint genes promotes clinical management and precision medicine in bladder carcinoma.
Shi WW; Guan JZ; Long YP; Song Q; Xiong Q; Qin BY; Ma ZQ; Hu Y; Yang B
Front Oncol; 2022; 12():915662. PubMed ID: 36033441
[TBL] [Abstract][Full Text] [Related]
20. Identification of prognostic genes in adrenocortical carcinoma microenvironment based on bioinformatic methods.
Li X; Gao Y; Xu Z; Zhang Z; Zheng Y; Qi F
Cancer Med; 2020 Feb; 9(3):1161-1172. PubMed ID: 31856409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]